megestrol acetate has been researched along with Endometrial Neoplasms in 90 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 12 (13.33) | 18.2507 |
2000's | 29 (32.22) | 29.6817 |
2010's | 33 (36.67) | 24.3611 |
2020's | 16 (17.78) | 2.80 |
Authors | Studies |
---|---|
Fu, HC; Kung, FT; Lan, J; Lan, KC; Lin, H; Ou, YC; Tsai, YC; Wu, CH | 1 |
Ascione, M; Bifulco, G; Boccia, D; Buonfantino, C; Cafasso, V; De Angelis, MC; Della Corte, L; Giampaolino, P; Grasso, G; Gullo, G; Mercorio, A; Palumbo, M; Serafino, P; Verrazzo, P; Viciglione, F | 1 |
Liu, Z; Niu, J; Shi, C; Zhao, X | 1 |
Chen, X; Guan, J; Liao, J; Shan, W; Shao, W; Xu, Z; Yang, B | 1 |
Forget, AN; Kulkarni, A; Mallick, R; Ramsay, T; Weberpals, JI; Wright, NMA | 1 |
Chen, XJ; Cheng, YL; Du, Y; Guan, J; Gulinazi, Y; Liu, J; Luo, XZ; Ma, FH; Ning, CC; Shan, WW; Sun, L; Yang, BY; Yu, M; Zhang, HW; Zhu, Q | 1 |
Atiomo, W | 1 |
da Silva, VF; de Melo, AC; Paulino, E | 1 |
Gowri, V; Rawahi, TA; Shikeli, S | 1 |
Aghajani, R; Arab, M; Ghahghaei-Nezamabadi, A; Khalagi, K; Sadeghi, S; Tehranian, A | 1 |
Christianson, MS; Cordeiro Mitchell, CN; Garbose, RA; Gornet, ME; Hunkler, KF; Maher, JY; Whiting-Collins, LJ | 1 |
Chung, YS; Kim, S; Kim, SW; Kim, YT; Lee, JY; Nam, EJ; Park, E; Woo, HY | 1 |
He, Y; Wang, J; Wang, Y; Zhou, R | 1 |
Cho, A; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Lee, SW; Park, JY; Suh, DS | 1 |
Catena, U; Fanfani, F; Masciullo, V; Moroni, R; Scambia, G; Trivellizzi, N; Zannoni, G | 1 |
Chen, X; Cheng, Y; Luo, X; Lv, Q; Shan, W; Sun, L; Wu, P; Yang, B; Zhang, H; Zhu, Q | 1 |
Choi, YM; Kim, H; Kim, SH; Kim, SW; Ku, SY; Suh, CS | 1 |
Li, L; Lin, J; Lou, H; Wang, F; Xu, H; Yu, A; Yu, H; Zhang, X | 1 |
Dellinger, TH; Finlay, J; Glackin, CA; Han, ES; Lowe, G; Roberts, CM; Wen, W | 1 |
Chen, X; Luo, X; Ning, C; Shan, W; Shi, Y; Xie, B; Xie, L; Xu, Y; Yang, B; Zhang, H; Zhu, Q | 1 |
Liu, H; Wang, H; Wang, J; Wang, Y; Zhou, R | 1 |
Basaran, D; Boran, N; Comert, GK; Kar, I; Karalok, A; Kilic, C; Turan, T; Turkmen, O; Yucel, O | 1 |
Jiang, ZX; Ju, XZ; Ren, YL; Shan, BE; Sun, JM; Tu, XY; Wang, HY; Zang, RY | 1 |
Bae, DS; Kim, DY; Kim, JH; Kim, JW; Kim, TJ; Kim, YM; Kim, YT; Nam, JH; Park, JY | 1 |
Dongol, S; Gao, X; Jiang, J; Lv, QT; Qiu, C | 1 |
Cao, DY; Cheng, NH; Deng, CY; He, FF; Huang, HF; Shen, K; Sun, ZY; Yang, JX; Yu, M; Yu, Q | 1 |
Burke, JJ; Davidson, SA; Downey, G; Filiaci, VL; Fleming, GF; Hanjani, P; Leslie, KK; Makker, V; Marzullo, B; Pearl, M; Reyes, HD; Van Le, L; Walker, JL; Zaino, RJ; Zweizig, SL | 1 |
Clarke, BA; Feigenberg, T; Ferguson, SE; Gien, LT; Ismiil, N; Laframboise, S; Massey, C; Simpson, AN | 1 |
Bogani, G; Carnelli, M; Frigerio, L; Grosso, G; Rossetti, D; Vitale, SG | 1 |
Bulun, SE; Coon, JS; Dyson, M; Kim, JJ; Malpani, S; Mittal, N; Ono, M; Pavone, ME; Schink, JC | 1 |
Bidadi, S; Foroughi, M; Ghojazadeh, M; Melli, MS; Tabrizi, AD | 1 |
Del Giudice, M; Falcone, F; Greggi, S; Laurelli, G; Losito, S; Messalli, EM; Scaffa, C | 1 |
Bi, Y; Chen, M; Jin, Y; Li, Y; Pan, L; Shan, Y | 1 |
Behbakht, K; Birrer, MJ; Burke, JJ; Downey, G; Filiaci, VL; Fleming, GF; Hanjani, P; Leslie, KK; Makker, V; Myers, AP; Pearl, M; Van Hummelen, P; Zhang, Y; Zweizig, S | 1 |
Cetinkaya, N; Erkaya, S; Gungor, T; Yalcin, H; Zergeroglu, S | 1 |
Di Napoli, M; Falcone, F; Granata, V; Greggi, S; Laurelli, G; Losito, S | 1 |
Chetaille, E; Geniaux, A; Green, JA; Hall, G; Joly, F; Kutarska, E; Lisyanskaya, A; Melichar, B; Oaknin, A; Ostapenko, V; Pautier, P; Reed, N; Shoaib, M; Vergote, I; Zvirbule, Z | 1 |
Franco, EL; Gotlieb, WH; Greenwald, ZR; Huang, LN; Wissing, MD | 1 |
Baiocco, E; Carosi, M; Corrado, G; Vizza, E | 1 |
Ergun, B; Iyibozkurt, C; Kalelioğlu, I; Topuz, S | 1 |
Han, AR; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Kwon, YS; Nam, JH | 1 |
Buist, MR; Dahhan, T; Fons, G; Ten Kate, FJ; van der Velden, J | 1 |
Eftekhar, Z; Izadi-Mood, N; Mohagheghi, S; Rezaei, Z; Shojaei, H; Yarandi, F | 1 |
Bogliatto, F; Leidi, L; Morero, S; Mosso, L; Sodano, M; Torchio, B | 1 |
Huo, Z; Lang, JH; Shen, K; Wu, M; Yang, JX; Yu, M | 1 |
Hahn, HS; Hong, JS; Hong, SR; Kim, TJ; Kwon, YS; Lee, IH; Lee, KH; Lim, JY; Lim, KT; Mok, JE; Park, SJ; Shim, JU; Yoon, SG | 1 |
Chen, Y; Lv, W; Mao, Y; Wan, X; Xie, X | 1 |
Lee, S; Lim, MC; Seo, SS | 1 |
Del Giudice, M; Di Vagno, G; Greggi, S; Laurelli, G; Losito, S; Scaffa, C | 1 |
Park, H; Seong, SJ; Yoon, BS | 1 |
Eftekhar, Z; Khazaeipour, Z; Shirali, E; Shojaei, H; Yarandi, F | 1 |
Feng, CP; Jin, Y; Li, HJ; Lin, H; Pan, XY; Wang, YN | 1 |
Atkins, KA; Hanley, KZ; Mentrikoski, MJ; Shah, AA | 1 |
Bae, DS; Kim, DY; Kim, JH; Kim, JW; Kim, KR; Kim, SM; Kim, TJ; Kim, YM; Kim, YT; Nam, JH; Park, JY; Seong, SJ | 1 |
Cui-Ping, F; Hua, L; Hua-Jun, L; Xiao-Yu, P; Ya-Nan, W; Yan, J | 1 |
Bae, DS; Kim, JW; Kim, SM; Kim, TJ; Nam, JH; Park, JY; Seong, SJ | 1 |
Bae, DS; Kim, DY; Kim, JH; Kim, JW; Kim, TJ; Kim, YM; Kim, YT; Lee, SH; Nam, JH; Park, JY; Seong, SJ | 1 |
Deavers, MT; Gershenson, DM; Malpica, A; Parlow, AF; Silva, EG | 1 |
Aksu, T; Ayhan, A; Bozdag, G; Yarali, H | 1 |
Herzog, TJ | 1 |
Andersen, W; Brunetto, VL; Fiorica, JV; Hanjani, P; Lentz, SS; Mannel, R | 1 |
Balos, LL; Dare, AO; Fenstermaker, RA; Gruber, T; Lele, S | 1 |
Blanchard, R; Hamid, AM; Leiser, AL | 1 |
Aoki, D; Banno, K; Nozawa, S; Susumu, N; Suzuki, A; Suzuki, N; Tamada, Y | 1 |
Chang, YC; Huang, SY; Jung, SM; Lai, CH; Ng, KK | 1 |
Chang, CL; Chen, CP; Wang, KL; Wu, CC; Yang, YC | 1 |
Frumovitz, M; Gershenson, DM | 1 |
Kadioğlu, P; Ozguroglu, M; Turna, H; Yildiz, O | 1 |
Mlyncek, M; Ravinger, J; Uharcek, P | 1 |
Lin, QH; Zhang, Y | 1 |
Aydiner, A; Karagol, H; Kucucuk, S; Saip, P; Topuz, E; Uygun, K | 1 |
Denschlag, D; Gilbert, L; Kerim-Dikeni, A; Patel, S; Souhami, L; Tan, L | 1 |
Del Priore, G; Hartzfeld, KM; Hurst, SA | 1 |
Ayhan, A; Bozdag, G; Demirol, A; Gurgan, T | 1 |
Baker, TR; Cornelison, TL; Driscoll, DL; Piver, MS | 1 |
Chao, AS; Hsueh, S; Lai, CH; Soong, YK | 1 |
Bigler, LR; Gams, RA; Spencer, DM; Wilkin, JK | 1 |
Borruto Caracciolo, G; Caccavale, C; Cardone, A; Di Serio, C; Tolino, A | 1 |
Rose, PG | 1 |
Brady, MF; Lentz, SS; Major, FJ; Reid, GC; Soper, JT | 1 |
Cavanagh, D; Fiorica, JV; Hoffman, MS; Nicosia, SV; Pinelli, DM; Roberts, WS | 1 |
Ghosh, K; Holschneider, CH; Kim, YB; Montz, FJ; Nieberg, RK | 1 |
Hyder, SM; Murthy, L; Stancel, GM | 1 |
Scribner, DR; Walker, JL | 1 |
Jacques, SM; Kowalczyk, CL; Leach, RE; Malone, J; Peterson, EP | 1 |
Eltabbakh, GH; Garafano, LL; Hammond, JM; Moody, J | 1 |
Hoffmann, O; Oberhoff, C; Schindler, AE; Winkler, UH | 1 |
Bender, D; Davis, W; Lowe, MP; Sood, AK; Sorosky, JI; Syrop, CH | 1 |
Emons, G; Hinney, B; Huschmand, H; Krauss, T; Viereck, V | 1 |
Chou, HH; Hsueh, S; Huang, HJ; Lai, CH; Soong, YK; Wang, CB; Wang, CJ | 1 |
8 review(s) available for megestrol acetate and Endometrial Neoplasms
Article | Year |
---|---|
Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Ki-67 Antigen; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; NF-E2-Related Factor 2; Pregnancy; Progestins; Survivin | 2022 |
Conservative management of grade 2 stage IA endometrial carcinoma and literature review.
Topics: Antineoplastic Agents, Hormonal; Conservative Treatment; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Megestrol Acetate; Pregnancy; Retrospective Studies; Treatment Outcome | 2021 |
Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series and review of the literature.
Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Cohort Studies; Disease Management; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Megestrol Acetate; Neoplasm Grading; Neoplasm Staging; Organ Sparing Treatments; Pilot Projects; Pregnancy; Pregnancy Rate; Sarcoma; Uterus; Young Adult | 2015 |
[Conservative hormonal therapy for endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Neoplasm Staging; Treatment Outcome | 2004 |
Fertility-sparing therapy for young women with endometrial cancer.
Topics: Adult; Age of Onset; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Patient Selection; Pregnancy; Pregnancy Outcome; Prognosis | 2006 |
Preserving fertility before assisted reproduction in women with endometrial carcinoma: case report and literature review.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility; Humans; Megestrol Acetate; Minimally Invasive Surgical Procedures; Reproductive Techniques, Assisted | 2007 |
Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Premenopause; Treatment Outcome | 1997 |
[Hormonal therapy and chemotherapy of endometrial cancer].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Staging; Palliative Care | 2002 |
15 trial(s) available for megestrol acetate and Endometrial Neoplasms
Article | Year |
---|---|
Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial pr
Topics: Antineoplastic Combined Chemotherapy Protocols; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Metformin; Obesity; Pregnancy; Prospective Studies; Randomized Controlled Trials as Topic | 2022 |
Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective, open-label, randomized controlled phase II trial (Clini
Topics: Endometrial Neoplasms; Endometrium; Female; Humans; Levonorgestrel; Megestrol Acetate; Prospective Studies | 2023 |
Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial.
Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; China; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Megestrol Acetate; Metformin; Middle Aged; Treatment Outcome; Young Adult | 2020 |
The impact of adjunctive metformin to progesterone for the treatment of non-atypical endometrial hyperplasia in a randomized fashion, a placebo-controlled, double blind clinical trial.
Topics: Adult; Antineoplastic Agents, Hormonal; Double-Blind Method; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Metformin | 2021 |
Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Sirolimus; Tamoxifen | 2014 |
Antiproliferative effect of metformin on the endometrium--a clinical trial.
Topics: Adult; Antineoplastic Agents, Hormonal; Atrophy; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Hypoglycemic Agents; Megestrol Acetate; Metformin; Metrorrhagia | 2014 |
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.
Topics: Class I Phosphatidylinositol 3-Kinases; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Mutation; Phosphatidylinositol 3-Kinases; Prospective Studies; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Sirolimus; Tamoxifen; Tuberous Sclerosis Complex 1 Protein; Tumor Suppressor Proteins | 2016 |
A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer.
Topics: Aged; Antineoplastic Agents, Hormonal; Disease-Free Survival; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Neoplasm Recurrence, Local; Receptors, Estrogen; Sulfonic Acids | 2017 |
Conservative treatment of early endometrial cancer: preliminary results of a pilot study.
Topics: Adult; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Endometrial Neoplasms; Female; Fertility; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Neoplasm Staging; Pilot Projects; Prospective Studies | 2011 |
Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Endometrioid; Cell Differentiation; Down-Regulation; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Middle Aged; Receptors, Progesterone; Tamoxifen | 2004 |
Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Chromosomes, Human, X; Endometrial Neoplasms; Estrogen Receptor alpha; Female; Fertility; Humans; Immunohistochemistry; Megestrol Acetate; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies; Receptors, Androgen; Receptors, Progesterone; Treatment Failure; X Chromosome Inactivation | 2005 |
Cisplatin, adriamycin, etoposide, megestrol acetate versus melphalan, 5-fluorouracil, medroxyprogesterone acetate in the treatment of endometrial carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Endometrial Neoplasms; Etoposide; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Melphalan; Middle Aged; Prospective Studies; Survival Rate | 1995 |
Tamoxifen, megestrol acetate, and beta interferon in endometrial cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Endometrial Neoplasms; Female; Humans; Interferon-beta; Megestrol; Megestrol Acetate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1995 |
High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Disease-Free Survival; Endometrial Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome | 1996 |
Chemotherapy plus sequential hormonal therapy for advanced and recurrent endometrial carcinoma: a phase II study.
Topics: Adult; Aged; Carboplatin; Carcinoma; Disease Progression; Drug Therapy, Combination; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Receptors, Estrogen; Receptors, Progesterone; Survival Analysis; Tamoxifen | 1996 |
67 other study(ies) available for megestrol acetate and Endometrial Neoplasms
Article | Year |
---|---|
The role of prolonged progestin treatment and factors predicting successful fertility-sparing treatment for early endometrial endometrioid adenocarcinoma.
Topics: Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Megestrol Acetate; Pregnancy; Progestins; Retrospective Studies; Treatment Outcome | 2021 |
Should we abandon hormonal therapy in endometrial cancer? Outcomes of recurrent and metastatic endometrial cancer treated with systemic progestins.
Topics: Antineoplastic Combined Chemotherapy Protocols; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Neoplasm Recurrence, Local; Progestins; Retrospective Studies | 2023 |
Is there any move to use metformin for endometrial hyperplasia in routine clinical practice?
Topics: Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Hypoglycemic Agents; Megestrol Acetate; Metformin | 2020 |
Endometrioid Carcinoma Arising from an Endometriosis-Associated Abdominal Wall Scar.
Topics: Abdominal Wall; Carcinoma, Endometrioid; Cicatrix; Endometrial Neoplasms; Endometriosis; Female; Humans; Hysterectomy; Megestrol Acetate; Middle Aged; Salpingo-oophorectomy | 2020 |
Fertility-Sparing Treatment in Young Women with Atypical Endometrial Hyperplasia and Low-Grade Endometrial Cancer: A Tertiary Center Experience.
Topics: Adult; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Treatment Outcome; Young Adult | 2020 |
Conservatively treated endometrial intraepithelial neoplasia/cancer: Risk of intrauterine synechiae.
Topics: Adult; Carcinoma in Situ; Conservative Treatment; Contraceptive Agents, Female; Dilatation and Curettage; Endometrial Neoplasms; Female; Gynatresia; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Live Birth; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Progestins; Retrospective Studies; Risk | 2021 |
Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Biomarkers; Biopsy; Disease Progression; DNA Mismatch Repair; DNA Polymerase II; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Humans; Hysterectomy; Intrauterine Devices, Medicated; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Mutation; Neoplasm Recurrence, Local; Prognosis; Receptors, Progesterone; Retrospective Studies; Tumor Suppressor Protein p53; Young Adult | 2021 |
Oncologic and obstetrical outcomes after fertility-preserving retreatment in patients with recurrent atypical endometrial hyperplasia and endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Outcome; Retreatment; Retrospective Studies; Young Adult | 2020 |
Continued medical treatment for persistent early endometrial cancer in young women.
Topics: Administration, Oral; Antineoplastic Agents, Hormonal; Biopsy; Carcinoma, Endometrioid; Disease-Free Survival; Drug Administration Schedule; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices; Levonorgestrel; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Megestrol Acetate; Myometrium; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prognosis; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome; Ultrasonography | 2021 |
Prognostic impact of hysteroscopic resection of endometrial atypical hyperplasia-endometrioid intraepithelial neoplasia and early-stage cancer in combination with megestrol acetate.
Topics: Abortion, Spontaneous; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Combined Modality Therapy; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Fertilization in Vitro; Humans; Hysteroscopy; Live Birth; Megestrol Acetate; Pregnancy; Pregnancy Rate; Prognosis; Prospective Studies | 2021 |
A successful live birth with in vitro fertilization and thawed embryo transfer after conservative treatment of recurrent endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Conservative Treatment; Cryopreservation; Embryo Transfer; Endometrial Neoplasms; Female; Fertility Preservation; Fertilization in Vitro; Humans; Letrozole; Levonorgestrel; Live Birth; Megestrol Acetate; Neoplasm Recurrence, Local; Nitriles; Pregnancy; Pregnancy Outcome; Triazoles | 2018 |
Fertility Preserved Hysteroscopic Approach for the Treatment of Stage Ia Endometrioid Carcinoma.
Topics: Adult; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Staging; Pregnancy; Retrospective Studies | 2017 |
Pterostilbene, a natural phenolic compound, synergizes the antineoplastic effects of megestrol acetate in endometrial cancer.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Endometrial Neoplasms; Female; Humans; MAP Kinase Signaling System; Megestrol Acetate; Mice, Nude; Phenols; Signal Transduction; STAT3 Transcription Factor; Stilbenes; Xenograft Model Antitumor Assays | 2017 |
Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer.
Topics: Administration, Oral; Adult; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Megestrol Acetate; Metformin; Middle Aged; Progestins; Retrospective Studies; Treatment Outcome; Young Adult | 2019 |
Impact of treatment duration in fertility-preserving management of endometrial cancer or atypical endometrial hyperplasia.
Topics: Adult; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Kaplan-Meier Estimate; Medroxyprogesterone; Megestrol Acetate; Pregnancy; Pregnancy Rate; Retrospective Studies; Treatment Outcome | 2019 |
Hormone therapy following surgery in low-grade endometrial stromal sarcoma: Is it related to a decrease in recurrence rate?
Topics: Adult; Combined Modality Therapy; Endometrial Neoplasms; Female; Humans; Hysterectomy; Lymph Node Excision; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Salpingo-oophorectomy; Sarcoma, Endometrial Stromal | 2019 |
A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women.
Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Combined Modality Therapy; Curettage; Endometrial Neoplasms; Endometrium; Feasibility Studies; Female; Fertility Preservation; Humans; Hyperplasia; Hysteroscopy; Megestrol Acetate; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Rate; Prospective Studies; Young Adult | 2013 |
Hormonal therapy for women with stage IA endometrial cancer of all grades.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Cohort Studies; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Pregnancy Outcome; Progestins; Retrospective Studies; Survival Rate; Treatment Outcome; Young Adult | 2013 |
Sterol regulatory element-binding protein-1/fatty acid synthase involvement in proliferation inhibition and apoptosis promotion induced by progesterone in endometrial cancer.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Fatty Acid Synthase, Type I; Female; Gene Expression Regulation, Neoplastic; Humans; Megestrol Acetate; Progesterone; Sterol Regulatory Element Binding Protein 1 | 2013 |
[Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
Topics: Adult; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Humans; Infertility, Female; Medroxyprogesterone; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Progestins; Reproductive Techniques, Assisted; Retrospective Studies; Treatment Outcome; Young Adult | 2013 |
Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysterectomy; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Organ Sparing Treatments; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Reproductive Techniques, Assisted; Retrospective Studies; Treatment Outcome | 2014 |
Efficacy of IVF following conservative management of endometrial cancer.
Topics: Adult; Endometrial Neoplasms; Female; Fertilization in Vitro; Humans; Megestrol Acetate; Ovulation Induction; Pregnancy | 2014 |
Fenretinide: a novel treatment for endometrial cancer.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Progression; Endometrial Neoplasms; Female; Fenretinide; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Megestrol Acetate; Membrane Proteins; Mice, Nude; Vitamin A; Xenograft Model Antitumor Assays | 2014 |
Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; China; Disease-Free Survival; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility; Fertility Preservation; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Obesity; Pregnancy; Progestins; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Clinicopathologic characteristics and treatment features of women with the incidental diagnosis of endometrial adenocarcinoma during infertility follow-up in Ankara, Turkey.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Incidental Findings; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Pregnancy Rate; Retrospective Studies; Turkey | 2016 |
Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Combined Modality Therapy; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Intrauterine Devices; Levonorgestrel; Megestrol Acetate; Pregnancy; Progestins; Prospective Studies; Young Adult | 2017 |
Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Cause of Death; Cohort Studies; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysterectomy; Kaplan-Meier Estimate; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Propensity Score; Proportional Hazards Models; SEER Program; Time Factors; United States | 2017 |
Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.
Topics: Abortion, Spontaneous; Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Endometrioid; Chemotherapy, Adjuvant; Disease Progression; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy; Hysteroscopy; Laparoscopy; Megestrol Acetate; Neoplasm Staging; Ovariectomy; Ovulation Induction; Precancerous Conditions; Pregnancy; Radiotherapy, Adjuvant; Treatment Failure | 2008 |
Conservative management of a patient with endometrial carcinoma desiring fertility: how to inform?
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility; Humans; Megestrol Acetate; Patient Participation; Pregnancy | 2008 |
Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endometrial adenocarcinoma or atypical complex hyperplasia.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Dilatation and Curettage; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Reproductive Techniques, Assisted; Retrospective Studies | 2009 |
The efficacy of hormonal treatment for residual or recurrent low-grade endometrial stromal sarcoma. A retrospective study.
Topics: Adult; Aged, 80 and over; Aromatase Inhibitors; Combined Modality Therapy; Dose-Response Relationship, Drug; Endometrial Neoplasms; Female; Humans; Hysterectomy; Letrozole; Megestrol Acetate; Middle Aged; Nitriles; Progestins; Retrospective Studies; Sarcoma, Endometrial Stromal; Secondary Prevention; Treatment Outcome; Triazoles | 2009 |
Efficacy of megestrol acetate (megace) in the treatment of patients with early endometrial adenocarcinoma: our experiences with 21 patients.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Fertility; Humans; Infertility, Female; Megestrol Acetate; Middle Aged; Prospective Studies; Young Adult | 2009 |
Case report: Successful IVF programme after conservatively treated endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Embryo Transfer; Endometrial Neoplasms; Female; Fertilization in Vitro; Humans; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Treatment Outcome | 2009 |
Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Antineoplastic Agents, Hormonal; Cell Differentiation; Combined Modality Therapy; Endometrial Neoplasms; Endometrium; Female; Fertility; Follow-Up Studies; Humans; Hydroxyprogesterones; Hyperplasia; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Progestins; Remission Induction; Reproductive Techniques, Assisted; Retrospective Studies; Severity of Illness Index | 2009 |
Conservative treatment with progestin and pregnancy outcomes in endometrial cancer.
Topics: Adult; Algorithms; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility; Follow-Up Studies; Gynecologic Surgical Procedures; Humans; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Progestins; Remission Induction; Retrospective Studies; Treatment Outcome; Young Adult | 2009 |
Outcomes of conservative therapy for young women with early endometrial adenocarcinoma.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Fertility; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Staging; Pregnancy; Pregnancy Outcome; Reproductive Techniques, Assisted; Retrospective Studies; Treatment Outcome | 2010 |
Megestrol acetate therapy for advanced low-grade endometrial stromal sarcoma.
Topics: Adult; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Endometrial Neoplasms; Fallopian Tubes; Female; Humans; Lung Neoplasms; Megestrol Acetate; Neoplasm Staging; Omentum; Ovariectomy; Palliative Care; Sarcoma, Endometrial Stromal | 2010 |
The effect of operative hysteroscopy conducted before progestin treatment in early stage endometrial cancer from the view of fertility.
Topics: Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Megestrol Acetate | 2011 |
Pregnancy outcome in patients with stage 1a endometrial adenocarcinoma, who conservatively treated with megestrol acetate.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysterectomy; Megestrol Acetate; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Receptors, Estrogen; Receptors, Progesterone; Treatment Outcome; Young Adult | 2012 |
[Regulation of claudin-4 gene expression in endometrial adenocarcinoma Ishikawa cell line by progesterone].
Topics: Adenocarcinoma; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Claudin-4; Endometrial Neoplasms; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Megestrol Acetate; Progesterone; Real-Time Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2012 |
Assessing endometrial hyperplasia and carcinoma treated with progestin therapy.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Cohort Studies; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Levonorgestrel; Megestrol Acetate; Menopause; Middle Aged; Prognosis; Treatment Failure; Young Adult | 2012 |
Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002).
Topics: Administration, Oral; Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Cohort Studies; Endometrial Neoplasms; Female; Fertility Preservation; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Prognosis; Survival Rate; Young Adult | 2013 |
Altered claudin-4 expression in progesterone-treated endometrial adenocarcinoma cell line Ishikawa.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Shape; Claudin-4; Dose-Response Relationship, Drug; Down-Regulation; Drug Evaluation, Preclinical; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Megestrol Acetate; Progesterone | 2012 |
Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer.
Topics: Abortion, Spontaneous; Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Disease-Free Survival; Endometrial Neoplasms; Female; Fertility Agents; Humans; Infant, Newborn; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Neoplasm Staging; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Rate; Pregnancy, Ectopic; Premature Birth; Retrospective Studies; Treatment Outcome; Young Adult | 2013 |
Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin.
Topics: Adenocarcinoma; Adult; Endometrial Neoplasms; Female; Fertility Preservation; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Progestins; Recurrence | 2013 |
Calcifications in ovary and endometrium and their neoplasms.
Topics: Animals; Calcinosis; Chorionic Gonadotropin; Clomiphene; Dihydrotestosterone; Endometrial Neoplasms; Endometrium; Estradiol; Estrone; Female; Growth Hormone; Guinea Pigs; Hormones; Megestrol Acetate; Ovarian Neoplasms; Ovary; Prolactin; Tamoxifen; Testosterone | 2003 |
A successful pregnancy after intracytoplasmic sperm injection and embryo transfer in a patient with endometrial cancer who was treated conservatively.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Cesarean Section; Embryo Transfer; Endometrial Neoplasms; Female; Humans; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Progesterone; Sperm Injections, Intracytoplasmic; Ultrasonography | 2004 |
What is the clinical value of adding tamoxifen to progestins in the treatment [correction for treament] of advanced or recurrent endometrial cancer?
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Drug Synergism; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Receptors, Progesterone; Tamoxifen | 2004 |
Multiple meningiomas arising during long-term therapy with the progesterone agonist megestrol acetate. Case report.
Topics: Dementia; Embolization, Therapeutic; Endometrial Neoplasms; Female; Gynecologic Surgical Procedures; Humans; Magnetic Resonance Imaging; Megestrol Acetate; Meningeal Neoplasms; Meningioma; Middle Aged; Neurosurgical Procedures; Progesterone; Progestins; Radiosurgery; Sarcoma, Endometrial Stromal; Time Factors | 2004 |
Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cord stromal component treated with progestin and aromatase inhibitor.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Endometrial Neoplasms; Enzyme Inhibitors; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Progestins; Prolactin; Sarcoma, Endometrial Stromal; Triazoles | 2004 |
Ovarian metastasis in a nulliparous woman with endometrial adenocarcinoma failing conservative hormonal treatment.
Topics: Adenocarcinoma; Adult; Combined Modality Therapy; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Ovarian Neoplasms | 2005 |
Megestrol acetate induced hypoadrenalism with cushingoid phenotype in endometrial cancer.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Endometrial Neoplasms; Female; Humans; Hydrocortisone; Megestrol Acetate; Middle Aged | 2006 |
Endometrial adenocarcinoma presenting with an osseous metastasis.
Topics: Adenocarcinoma; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Endometrial Neoplasms; Female; Humans; Hysterectomy; Megestrol Acetate; Middle Aged | 2006 |
[Progesterone-modulated proteins in human endometrial cancer cell line Ishikawa].
Topics: Adenocarcinoma; Cell Line, Tumor; Down-Regulation; Electrophoresis, Gel, Two-Dimensional; Endometrial Neoplasms; Female; Humans; Mass Spectrometry; Megestrol Acetate; Progesterone; Proteins; Proteome; Up-Regulation | 2006 |
Evaluation of prognostic factors and comparison of systemic treatment modalities in patients with recurrent or metastatic endometrial carcinoma.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Paclitaxel; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2006 |
Stage III endometrial cancer: preoperative predictability, prognostic factors, and treatment outcome.
Topics: Adnexa Uteri; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Canada; Carcinoma; Chemotherapy, Adjuvant; Cystadenoma, Serous; Endometrial Neoplasms; Fallopian Tubes; Female; Humans; Hysterectomy; Lymph Node Excision; Megestrol Acetate; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Ovariectomy; Prognosis; Radiotherapy, Adjuvant; Registries | 2007 |
Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Dilatation and Curettage; Endometrial Neoplasms; Female; Fertility; Humans; Hysterectomy, Vaginal; Hysteroscopy; Infertility, Female; Laparoscopy; Magnetic Resonance Imaging; Megestrol Acetate; Myometrium; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Ovariectomy; Pregnancy; Progestins; Quality of Life; Reproductive Techniques, Assisted; Surrogate Mothers; Treatment Outcome | 2008 |
Successful pregnancy after tamoxifen and megestrol acetate therapy for endometrial carcinoma.
Topics: Adenocarcinoma; Adult; Endometrial Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Pregnancy; Tamoxifen | 1994 |
Uterine adenocarcinoma metastatic to the skin responsive to megestrol acetate.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Drug Resistance; Endometrial Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Skin Neoplasms | 1994 |
Hyperglycemia secondary to megestrol acetate for endometrial neoplasia.
Topics: Adenocarcinoma; Adenoma; Antineoplastic Agents; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hyperglycemia; Insulin; Megestrol; Megestrol Acetate; Middle Aged | 1996 |
Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Topics: Breast Neoplasms; Endometrial Neoplasms; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphokines; Medroxyprogesterone Acetate; Megestrol Acetate; Mifepristone; Neoplasm Proteins; Neovascularization, Pathologic; Norethindrone; Norethynodrel; Norgestrel; Progesterone; Progestins; Receptors, Progesterone; Stimulation, Chemical; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
Low-grade endometrial stromal sarcoma preoperative treatment with Depo-Lupron and Megace.
Topics: Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Leuprolide; Megestrol Acetate; Middle Aged; Sarcoma, Endometrial Stromal | 1998 |
Well-differentiated endometrial adenocarcinoma in an infertility patient with later conception. A case report.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Diagnosis, Differential; Endometrial Neoplasms; Female; Fertilization; Humans; Infertility, Female; Megestrol Acetate; Pregnancy | 1999 |
The combination paclitaxel, carboplatin and megestrol acetate is effective in women with recurrent uterine papillary serous adenocarcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cystadenocarcinoma, Papillary; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Paclitaxel; Prognosis; Treatment Outcome | 1999 |
Hemostatic effects of high-dose megestrol acetate therapy in patients with advanced gynecological cancer.
Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation; Breast Neoplasms; Endometrial Neoplasms; Female; Fibrinolysis; Genital Neoplasms, Female; Humans; Megestrol Acetate; Middle Aged; Ovarian Neoplasms; Thrombosis | 2001 |
Two successful pregnancies after conservative treatment of endometrial cancer and assisted reproduction.
Topics: Adenocarcinoma; Adult; Delivery, Obstetric; Endometrial Neoplasms; Endometrium; Female; Humans; Infant, Newborn; Megestrol Acetate; Pregnancy; Reproductive Techniques, Assisted | 2002 |
Fertility-preserving treatment in young patients with endometrial adenocarcinoma.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Disease Progression; Endometrial Neoplasms; Female; Fertility; Gonadotropin-Releasing Hormone; Humans; Megestrol; Megestrol Acetate; Pelvis; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Treatment Outcome; Ultrasonography | 2002 |